Financière de Tubize SA (TUB.BR)

EUR 115.8

(3.95%)

Long Term Debt Summary of Financière de Tubize SA

Financière de Tubize SA's latest annual long term debt in 2023 was - EUR , down 0.0% from previous year.
Financière de Tubize SA's latest quarterly long term debt in 2024 Q2 was - EUR , down 0.0% from previous quarter.
Financière de Tubize SA reported annual long term debt of - EUR in 2022, down 0.0% from previous year.
Financière de Tubize SA reported annual long term debt of - EUR in 2021, down 0.0% from previous year.
Financière de Tubize SA reported quarterly long term debt of - EUR for 2023 FY, down 0.0% from previous quarter.
Financière de Tubize SA reported quarterly long term debt of - EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Financière de Tubize SA (2023 - 2003)

Historical Annual Long Term Debt of Financière de Tubize SA (2023 - 2003)

Year	Long Term Debt	Long Term Debt Growth
2023	- EUR	0.0%
2022	- EUR	0.0%
2021	- EUR	0.0%
2020	- EUR	-100.0%
2019	34 Million EUR	-62.22%
2018	90 Million EUR	-35.71%
2017	140 Million EUR	-0.71%
2016	141 Million EUR	-40.49%
2015	236.93 Million EUR	71.31%
2014	138.3 Million EUR	-17.18%
2013	167 Million EUR	-24.23%
2012	220.39 Million EUR	-12.4%
2011	251.59 Million EUR	-11.66%
2010	284.79 Million EUR	-8.86%
2009	312.49 Million EUR	-5.3%
2008	330 Million EUR	0.0%
2007	- EUR	-100.0%
2006	193.9 Million EUR	163.46%
2005	73.6 Million EUR	-18.34%
2004	90.13 Million EUR	-27.37%
2003	124.1 Million EUR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	- EUR	0.0%
2023 FY	- EUR	0.0%
2023 Q2	- EUR	0.0%
2023 Q4	- EUR	0.0%
2022 Q2	- EUR	0.0%
2022 FY	- EUR	0.0%
2022 Q4	- EUR	0.0%
2021 FY	- EUR	0.0%
2021 Q4	- EUR	0.0%
2021 Q2	- EUR	0.0%
2020 FY	- EUR	-100.0%
2020 Q4	- EUR	0.0%
2020 Q2	- EUR	0.0%
2019 Q2	33.5 Million EUR	0.0%
2019 Q4	34 Million EUR	0.0%
2019 FY	34 Million EUR	-62.22%
2018 Q4	90 Million EUR	0.0%
2018 FY	90 Million EUR	-35.71%
2018 Q2	86.5 Million EUR	0.0%
2017 Q2	89 Million EUR	0.0%
2017 FY	140 Million EUR	-0.71%
2017 Q4	140 Million EUR	0.0%
2016 FY	141 Million EUR	-40.49%
2016 Q2	238 Million EUR	0.0%
2016 Q4	141 Million EUR	0.0%
2015 FY	236.93 Million EUR	71.31%
2015 Q2	128.95 Million EUR	0.0%
2015 Q4	236.93 Million EUR	0.0%
2014 Q4	138.3 Million EUR	0.0%
2014 Q2	152.65 Million EUR	0.0%
2014 FY	138.3 Million EUR	-17.18%
2013 FY	167 Million EUR	-24.23%
2013 Q4	167 Million EUR	0.0%
2013 Q2	205.05 Million EUR	0.0%
2012 Q4	220.39 Million EUR	0.0%
2012 Q2	262.62 Million EUR	0.0%
2012 FY	220.39 Million EUR	-12.4%
2011 Q2	249.44 Million EUR	0.0%
2011 FY	251.59 Million EUR	-11.66%
2011 Q4	251.59 Million EUR	0.0%
2010 Q2	301.09 Million EUR	0.0%
2010 FY	284.79 Million EUR	-8.86%
2010 Q4	284.79 Million EUR	0.0%
2009 Q4	312.49 Million EUR	0.0%
2009 FY	312.49 Million EUR	-5.3%
2008 FY	330 Million EUR	0.0%
2007 FY	- EUR	-100.0%
2006 FY	193.9 Million EUR	163.46%
2005 FY	73.6 Million EUR	-18.34%
2004 FY	90.13 Million EUR	-27.37%
2003 FY	124.1 Million EUR	0.0%

Peer Long Term Debt Comparison of Financière de Tubize SA

Name	Long Term Debt	Long Term Debt Difference
Nicox S.A.	25.15 Million EUR	100.0%
European Medical Solutions	12.71 Million EUR	100.0%
FERMENTALG	14.33 Million EUR	100.0%
argenx SE	15.35 Million EUR	100.0%
BioSenic S.A.	15.57 Million EUR	100.0%
Celyad Oncology SA	902 Thousand EUR	100.0%
Hyloris Pharmaceuticals SA	344 Thousand EUR	100.0%
Onward Medical N.V.	16.3 Million EUR	100.0%
Oxurion NV	117 Thousand EUR	100.0%
PHAXIAM Therapeutics S.A.	7.03 Million EUR	100.0%
UCB SA	2.87 Billion EUR	100.0%